Goldman Sachs’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
Other funds holding AEMD
Goldman Sachs's AEMD Position: Q1 2023 in Review
Goldman Sachs sold out of Aethlon Medical (AEMD) in Q1 2023, closing a stake of 4 shares — an estimated $3.92K sold.
Goldman Sachs first reported a position in AEMD in Q4 2022 and held it in 1 quarter. The position peaked at $3.92K in Q4 2022. 20 funds tracked by Wall St. Rank hold AEMD as of Q1 2023.
- Goldman Sachs reported no remaining Aethlon Medical position as of Q1 2023 after selling out during the quarter.
- Goldman Sachs sold 4 Aethlon Medical shares in Q1 2023, an estimated $3.92K.
- Goldman Sachs first reported a position in Aethlon Medical in Q4 2022 and held it in 1 quarter.
- Goldman Sachs's Aethlon Medical position peaked at $3.92K in Q4 2022.
- 20 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2023.
Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.